Enduring Activity

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 7.25 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc.; Exelixis, Inc.; Genentech, Inc.; Incyte Corporation; Lilly; Merck & Co., Inc.; and Taiho Oncology, Inc.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

5th Annual School of Gastrointestinal Oncology™ (SOGO®)

5th Annual School of Gastrointestinal Oncology™ (SOGO®)

Saturday, March 21, 2020 - Live Webcast


Physicians’ Education Resource®, LLC, understands the concerns surrounding the outbreak and spread of the coronavirus (COVID-19) currently affecting several countries. After monitoring the situation and information being shared by the CDC, and taking into account current travel restrictions, we have decided that the 5th Annual School of Gastrointestinal Oncology™ (SOGO®) will be hosted as a live virtual webcast. Be assured that there is nothing more important to us than the safety of our participants which is why we are changing this to an online-only format.

5th Annual School of Gastrointestinal Oncology™ (SOGO®) Overview

Physicians’ Education Resource®, LLC (PER®), presents the 5th Annual School of Gastrointestinal Oncology (SOGO®), a 1-day, multidisciplinary, educational conference dedicated to exploring emerging therapies and evolving standards of care in the management of patients with gastrointestinal (GI) tumors, with a focus on providing attendees with the tools to individualize patient care.

In GI cancer, solid tumors are often difficult to treat because of their heterogeneity. Optimized management of this disease requires a high level of multidisciplinary cooperation and multimodality treatment regimens, when appropriate. The rapid pace of emerging developments creates knowledge and competence gaps for physicians who treat patients with GI cancers.

Led by world-renowned experts John L. Marshall, MD, and Michael A. Choti, MD, MBA, FACS, this multi-track symposium, now in its fifth year, will provide attendees with the tools needed to personalize care for each one of their patients with GI cancer. The program will include various modules that feature general presentations on important concepts in the field, along with separate side tracks to provide workshops geared toward personalized learning in smaller and more intimate settings. With 3 tracks–medical oncology, surgical and radiation oncology, and case-based SOGO Seminars—the program is designed to match the learning interests of everyone who attends.

This year’s symposium will once again feature the dynamic and interactive Medical Crossfire® format, where experts will engage in a rigorous debate to answer questions and reach consensus on ongoing paradigm shifts. The program will also feature case-based lectures by expert faculty that explore the latest data on prognostic and predictive biomarkers that impact clinical decision-making, and current and emerging treatment strategies. The focus will be on the practical application of this information to real-world, complex patient-care scenarios that exemplify key decision-making in diagnostic testing, upfront multidisciplinary planning, and management of treatment. PER® will continue to use its proven educational modalities to provide for a highly interactive meeting that fosters discussion and exchange of ideas, best practices, and cross-team cooperation in the clinic. This will include case-based tumor boards, question-and-answer sessions, ARS polling, and networking opportunities.

“The evolution of treating patients who have GI cancers has really transformed over the past few years and will continue to do so moving forward. We know that personalizing disease in these tumors has to be done, and we need to involve the entire clinical team to do so. The expanded role of immune therapies, the importance of multidisciplinary care, and the role of precision medicine has further complicated the pathways of care. With all the advances that have been made in both treatment and care management, we have turned GI cancer into a chess game, and we need to make sure all the players and pieces are working together. This meeting will continue to educate the treatment team through multiple presentations and small group discussions and will truly be the most unique GI cancers meeting around.”

— John Marshall, MD
Director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers
Georgetown University Medical Center
Washington, DC

Benefits of Attending

  • Build on learned information with insights from leading clinical experts on established and emerging treatment options in the management of GI cancer
  • Implement protocols to support best practice treatment selection for your patients with GI cancer
  • Amplify efforts to circumvent and manage treatment-associated adverse events for patients with GI cancer
  • Network with your colleagues with different clinical expertise who manage patients with GI cancer

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc.; Exelixis, Inc.; Genentech, Inc.; Incyte Corporation; Lilly; Merck & Co., Inc.; and Taiho Oncology, Inc.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Target Audience

This educational program is directed toward oncologists and gastroenterologists whose primary practice focus is GI cancers, and who intend to reinforce their knowledge base and expand their expertise in GI diagnosis, risk stratification, personalization of care, and best practices for multidisciplinary communication. Participants will be primarily oncologists, gastroenterologists, or fellows-in-training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of GI cancers.

Learning Objectives

  • Outline prognostic and predictive molecular markers that inform diagnosis and provide treatment guidance for patients with GI malignancies.
  • Consider results from pivotal and practice changing clinical trials assessing new strategies for the treatment and management of patients with GI malignancies.
  • Implement novel treatment strategies into clinical practice to improve the outcomes of patients with GI malignancies.
  • Determine a comprehensive sequencing plan for GI malignancies’ management in the context of multidisciplinary collaboration between interventional radiology, surgical oncology, and medical oncology
  • Assess methods to proactively plan for and mitigate the impact of treatment-related toxicities among patients with GI tumors

5th Annual School of Gastrointestinal Oncology™ (SOGO®) Program Co-Chairs

John L. Marshall
John L. Marshall, MD
Chief, Division of Hematology/Oncology
Medstar Georgetown University Hospital
Director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers
Georgetown University Medical Center
Washington, DC
Michael A. Choti
Michael A. Choti, MD, MBA, FACS
Chief of Surgery
Banner MD Anderson Cancer Center
Phoenix, AZ

5th Annual School of Gastrointestinal Oncology™ (SOGO®) Registration

Physicians' Education Resource - SOGO20
2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Registration Fees

Physicians $50
Fellows* $50
Nurses, Physician Assistants, Other Healthcare Professionals $50
Industry** $75

*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

A cancellation fee of 25% will be assessed on refunds requested prior to January 21, 2020, and a 50% fee on refunds requested on January 21, 2020 through February 21, 2020. No refunds will be made after February 21, 2020. There is no charge for substitution. Substitutions can be applied only to the same conference, and just 2 substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians’ Education Resource®, LLC (PER®), fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.

By attending a PER® conference, meeting, or related activity (“Events”), all participants, attendees, exhibitors, sponsors, and guests (“you”) create an agreement between you and PER® regarding the use and distribution of your image, including, but not limited to, your name, voice, and likeness (“Image”). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Now a LIVE WEBCAST! 5th Annual School of Gastrointestinal Oncology™ (SOGO®)
(7:00 - 4:50 pm EDT)"/>

Registration Information

In case of onsite emergency:

Professional Information


Calendar of Events
Filter By